Market Cap | ₹50Cr |
ROE | 1.59% |
P/E Ratio(TTM) | 45.45 |
EPS(TTM) | 0.77 |
P/B Ratio | 1.95 |
Dividend Yield | 0.00% |
Industry P/E | 40.02 |
Book Value | 17.98 |
Debt to Equity | 0.01 |
Face Value | 10 |
Parent Organisation | Bacil Pharma Limited |
BSE Symbol | 524516 |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Divi's Laboratories | NA (0.00%) | 69.07 | ||
Neuland Laboratories | NA (0.00%) | 104.99 | ||
Jubilant Pharmova | NA (0.00%) | 38.42 | ||
Acutaas Chemicals | NA (0.00%) | 64.65 |